Longevity Health Holdings Inc (NASDAQ: XAGE) has seen a rise in its stock price by 12.50 in relation to its previous close of 0.16. However, the company has experienced a 9.69% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-10 that Pittsburgh, PA, March 10, 2025 (GLOBE NEWSWIRE) — PITTSBURGH, Mar. 10, 2025 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX; CTCXW), a bio-aesthetics company (the “Company”, “we”, “our”, or “us”), today announced a comprehensive corporate rebranding initiative aimed at better aligning the Company’s market and investor facing image with its business focus and growth strategy. As part of the rebranding, the Company has changed its corporate name to “Longevity Health Holdings, Inc.” and, at the open of trading on March 10, 2025, the Company’s common stock and redeemable warrants will begin trading under the symbols “XAGE” and “XAGEW”, respectively.
Is It Worth Investing in Longevity Health Holdings Inc (NASDAQ: XAGE) Right Now?
Company’s 36-month beta value is 0.71.
The public float for XAGE is 22.68M, and currently, short sellers hold a 20.30% ratio of that floaft. The average trading volume of XAGE on May 02, 2025 was 6.37M shares.
XAGE’s Market Performance
XAGE’s stock has seen a 9.69% increase for the week, with a 39.18% rise in the past month and a -58.95% fall in the past quarter. The volatility ratio for the week is 9.94%, and the volatility levels for the past 30 days are at 18.71% for Longevity Health Holdings Inc The simple moving average for the past 20 days is 14.52% for XAGE’s stock, with a -58.47% simple moving average for the past 200 days.
XAGE Trading at -5.41% from the 50-Day Moving Average
After a stumble in the market that brought XAGE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.01% of loss for the given period.
Volatility was left at 18.71%, however, over the last 30 days, the volatility rate increased by 9.94%, as shares surge +33.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.54% lower at present.
During the last 5 trading sessions, XAGE rose by +9.69%, which changed the moving average for the period of 200-days by -89.49% in comparison to the 20-day moving average, which settled at $0.1533. In addition, Longevity Health Holdings Inc saw -37.12% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XAGE starting from Upton Richard A, who purchase 5,000 shares at the price of $0.47 back on Sep 13 ’24. After this action, Upton Richard A now owns 15,000 shares of Longevity Health Holdings Inc, valued at $2,336 using the latest closing price.
Gregory Kathryn, the Director of Longevity Health Holdings Inc, purchase 1,260 shares at $0.51 during a trade that took place back on Sep 06 ’24, which means that Gregory Kathryn is holding 22,500 shares at $643 based on the most recent closing price.
Stock Fundamentals for XAGE
Current profitability levels for the company are sitting at:
- -99.34 for the present operating margin
- -0.27 for the gross margin
The net margin for Longevity Health Holdings Inc stands at -236.55. The total capital return value is set at 1.14.
Based on Longevity Health Holdings Inc (XAGE), the company’s capital structure generated -0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -6.87. The debt to equity ratio resting at -0.14. The interest coverage ratio of the stock is -101.98.
Currently, EBITDA for the company is -10.5 million with net debt to EBITDA at -0.05. When we switch over and look at the enterprise to sales, we see a ratio of 114.63. The receivables turnover for the company is 0.16for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.15.
Conclusion
In a nutshell, Longevity Health Holdings Inc (XAGE) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
